Geoffrey Dow Buys Shares of SXTP $SXTP
Key Points
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
Geoffrey Dow, President and CEO at 60 Degrees Pharmaceuticals, Inc. ($SXTP), bought 7,350 shares at an average price of $1.38, for a total transaction of $10,143. The trade was disclosed in a Form 4 filing with the Securities and Exchange Commission.
60 Degrees Pharmaceuticals, Inc. Stock Up 44.7%
Shares of 60 Degrees Pharmaceuticals, Inc. ($SXTP) traded around $1.49 on Monday, up 44.7% for the day.
60 Degrees Pharmaceuticals, Inc. Earnings
Analysts Set New Price Targets
About 60 Degrees Pharmaceuticals, Inc.
60 Degrees Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the development and commercialization of therapies for the prevention and treatment of infectious diseases in the United States. It offers Arakoda for malaria prevention treatment. The company also engages in the development of Tafenoquine (Arakoda regimen) that is in Phase IIb clinical trial for COVID-19 indications; Tafenoquine, which is in phase IIA clinical trials for babesiosis, fungal and pneumocystis pneumonias, and candidiasis disease; and Celgosivir for Zika, respiratory viruses, and dengue fever. It also has patent license agreement with Tufts Medical Center to jointly advance the development and commercialization of tafenoquine for the treatment and prevention of babesiosis. 60 Degrees Pharmaceuticals, Inc. was founded in 2010 and is headquartered in Washington, District Of Columbia.
Get 60 Degrees Pharmaceuticals, Inc. alerts
New 13F filings, insider trades, and analyst moves on $SXTP, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.